Scale drop disease virus (SDDV), a novel member of the genus Megalocytivirus (species Megalocytivirus lates1), poses a major threat to marine aquaculture in Asia, particularly affecting Asian seabass (Lates calcarifer) and yellowfin seabream (Acanthopagrus latus). Here, we report the isolation and characterization of an SDDV strain, ZH-06/20, from diseased yellowfin seabream in South China. The virions exhibited typical icosahedral morphology with a diameter of ~140 nm. Complete genome sequencing revealed a 131,893 bp double-stranded DNA genome encoding 143 predicted proteins. Experimental infection caused 100% mortality in yellowfin seabream, accompanied by severe ascites but without scale drop lesions.
To develop control strategies, we evaluated vaccine efficacy. A formalin-inactivated SDDV vaccine conferred >97% protection in mandarin fish and >90% protection in field trials with yellowfin seabream. Furthermore, a bivalent inactivated vaccine containing ISKNV-I and SDDV provided robust cross-protection in Asian seabass against multiple megalocytivirus subtypes, achieving relative percent survival above 85%. For diagnostics, ten monoclonal antibodies (mAbs) targeting the SDDV major capsid protein were generated. All mAbs specifically recognized SDDV without cross-reactivity to other fish viruses. Selected mAbs bound intact virions and detected viral antigens in naturally infected tissues. Together, these findings advance understanding of SDDV biology and pathogenesis and establish effective vaccines and diagnostic reagents to mitigate the impact of this emerging pathogen in aquaculture.